Indo Borax & Chemicals to hold Earnings Call on June 2, 2026, to discuss Q4 & FY26 results
Indo Borax & Chemicals Limited will host an earnings call on June 2, 2026, to discuss Q4 & FY26 results. Highlights include Consolidated Operating Revenue of ₹215.45 Cr (FY26) vs ₹175.26 Cr (FY25) and Consolidated PAT of ₹50.27 Cr (FY26) vs ₹42.51 Cr (FY25). Management will present performance and answer queries.
The announcement concerns an upcoming earnings call to discuss financial results, which is a regular event for publicly listed companies. While it provides preliminary financial figures, the direct impact on the stock price is typically realized after the detailed results and management commentary during the call.
The announcement is a routine intimation about an upcoming earnings call to discuss financial results. While the provided financial highlights show positive year-on-year growth, the primary purpose of the announcement is informational, making the sentiment neutral.
Indo Borax & Chemicals Limited (IBCL) has announced an earnings call to discuss its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The call is scheduled for Tuesday, June 2, 2026, at 4:00 PM IST.
The company, a leading manufacturer of boron-based chemicals with over 45 years of expertise, will present its financial performance for Q4 and FY26. The call will commence with key comments from the management, followed by an interactive Question and Answer session with participants. Representing IBCL on the call will be Mr. Suresh Katra, Managing Director & CEO, Mr. Harsh Malhotra, Executive Director, and Mr. Shashikant Bharuka, Chief Financial Officer.
Key financial highlights mentioned include Consolidated Operating Revenue of ₹215.45 crore for FY26 compared to ₹175.26 crore for FY25, and Consolidated PAT of ₹50.27 crore for FY26 compared to ₹42.51 crore for FY25. The company's manufacturing facility is located in Pithampur, Madhya Pradesh.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.